Primary Peritoneal Carcinoma (PPC) is a rare type of cancer that develops in the peritoneum, the thin layer of tissue that lines the abdominal cavity and covers many of the organs within it. It is closely related to epithelial ovarian and fallopian tube cancers because these cancers can have similar microscopic and biological characteristics. However, in PPC, the primary tumor is considered to arise from the peritoneal lining rather than from the ovary itself.
PPC can affect the peritoneal surfaces throughout the abdomen and may cause the accumulation of fluid, known as ascites. Because the disease can spread across the abdominal lining, patients may experience abdominal swelling, discomfort, changes in bowel habits, reduced appetite, or unexplained weight changes.
Early symptoms can sometimes be subtle and may resemble common gastrointestinal or abdominal conditions. A detailed evaluation is therefore important when symptoms persist or when imaging shows unexplained abnormalities within the abdominal cavity.
Symptoms of Primary Peritoneal Carcinoma
The symptoms of PPC can vary depending on the location and extent of the disease. Some patients may initially experience mild or nonspecific symptoms, while others may develop more noticeable abdominal problems as the disease progresses.
Common symptoms may include:
- Persistent abdominal discomfort or pain
- Abdominal swelling or increasing abdominal size
- Bloating or a feeling of pressure in the abdomen
- Early fullness while eating
- Loss of appetite
- Unexplained weight loss
- Nausea or indigestion
- Changes in bowel habits
- Constipation or diarrhea
- Increased urinary frequency or pelvic pressure
- Fatigue or weakness
- Accumulation of fluid in the abdomen, known as ascites
These symptoms are not specific to PPC and may occur with many other conditions. Persistent or unexplained symptoms should be evaluated by a qualified healthcare professional.
How Primary Peritoneal Carcinoma Develops
The peritoneum is made up of specialized cells that form a protective lining around the abdominal organs. In primary peritoneal carcinoma, abnormal cells develop within this lining and begin to grow uncontrollably.
As the cancer progresses, tumor cells may spread across different areas of the peritoneal cavity. This can result in multiple small or larger tumor deposits on the abdominal surfaces.
PPC may also be associated with involvement of the ovaries and fallopian tubes. In some patients, the ovaries may appear normal or have only limited involvement despite extensive peritoneal disease. This distinction helps specialists determine whether the cancer is classified as primary peritoneal carcinoma or another closely related gynecological malignancy.
Risk Factors for Primary Peritoneal Carcinoma
The exact cause of PPC is not always known. Certain factors may increase the likelihood of developing peritoneal or related gynecological cancers.
These may include:
- Increasing age
- A personal or family history of ovarian, fallopian tube, or related cancers
- Inherited genetic changes, including certain BRCA1 or BRCA2 mutations
- A history of related gynecological cancers
- Certain hereditary cancer syndromes
However, PPC can occur in individuals without any known risk factors. The presence of a risk factor does not mean that a person will necessarily develop the disease.
Diagnosis of Primary Peritoneal Carcinoma
Diagnosing PPC generally involves a combination of clinical evaluation, imaging studies, laboratory investigations, and pathological examination.
A CT scan of the abdomen and pelvis is commonly used to assess the peritoneal cavity and identify abnormalities such as ascites, peritoneal thickening, tumor deposits, or involvement of nearby organs.
Additional imaging, including MRI or other specialized investigations, may be recommended in selected patients to provide further information about the disease.
Blood tests may include tumor markers such as CA-125, which can sometimes be elevated in PPC. However, tumor markers alone cannot confirm the diagnosis and must be interpreted alongside imaging and clinical findings.
A tissue biopsy is generally required to establish a definitive diagnosis. The biopsy is examined by a specialist pathologist to determine the type and characteristics of the cancer. Immunohistochemical testing may be used to distinguish PPC from other cancers that can spread to the peritoneum.
Staging and Assessment of Disease
Once PPC has been diagnosed, determining the extent of disease is an important part of treatment planning.
Specialists evaluate whether the cancer is limited to the abdominal cavity or has spread to other areas. Imaging studies help identify the distribution of tumor deposits, involvement of abdominal organs, lymph nodes, and the presence of ascites.
During surgery, the surgeon may directly assess the peritoneal cavity to determine the amount and distribution of tumor. In cases involving peritoneal surface disease, scoring systems such as the Peritoneal Cancer Index (PCI) may be used to estimate the extent of tumor involvement.
The overall disease burden, tumor biology, general health, and the possibility of achieving complete or near-complete removal of visible disease are important considerations when developing a treatment plan.